Mobia Medical completes IPO, implements staggered board and anti-takeover provisions

Filed May 11, 2026 · Period ending May 11, 2026 · ~1 min read

Key Changes

• high

  Company closed its initial public offering on May 11, 2026, transitioning to publicly traded status with increased regulatory requirements and disclosure obligations.

  Item 5.03 verify on EDGAR →
• high

  Authorized 950 million common shares and 50 million blank-check preferred shares that the board can issue without shareholder approval, providing flexibility for future financings or defensive measures.

  Item 5.03 verify on EDGAR →
• medium

  Implemented classified board with staggered three-year terms and supermajority (two-thirds) vote requirement to remove directors, making it harder for activists or acquirers to gain board control.

  Item 5.03 verify on EDGAR →